Stem cell therapy for acute myocardial infarction: Mesenchymal Stem Cells and induced Pluripotent Stem Cells
暂无分享,去创建一个
[1] Wan Safwani Wan Kamarul Zaman,et al. Mechanotransduction of mesenchymal stem cells (MSCs) during cardiomyocytes differentiation , 2022, Heliyon.
[2] M. Delgobo,et al. Myocardial-Treg Crosstalk: How to Tame a Wolf , 2022, Frontiers in Immunology.
[3] M. Wojciechowska,et al. Insight into the Role of the PI3K/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic Heart , 2022, Cells.
[4] K. Kawabata,et al. Transient ETV2 Expression Promotes the Generation of Mature Endothelial Cells from Human Pluripotent Stem Cells. , 2022, Biological & pharmaceutical bulletin.
[5] Moein Ala,et al. The Footprint of Kynurenine Pathway in Cardiovascular Diseases , 2022, International journal of tryptophan research : IJTR.
[6] J. Hare,et al. Mechanism of Action of Mesenchymal Stem Cells (MSCs): impact of delivery method , 2021, Expert opinion on biological therapy.
[7] H. Ghanbarian,et al. MicroRNAs and Exosomes: Cardiac stem cells in heart diseases , 2021, Pathology - Research and Practice.
[8] Jianyi(Jay) Zhang,et al. Basic and Translational Research in Cardiac Repair and Regeneration , 2021, Journal of the American College of Cardiology.
[9] F. Fernández‐Avilés,et al. Intracoronary Delivery of Porcine Cardiac Progenitor Cells Overexpressing IGF-1 and HGF in a Pig Model of Sub-Acute Myocardial Infarction , 2021, Cells.
[10] Michael E. Hall,et al. Impact of New ICD Codes on Acute MI Characteristics and Outcomes: What You Call It Matters. , 2021, Journal of the American College of Cardiology.
[11] E. Kizana,et al. Pluripotent stem cell-derived mesenchymal stromal cells improve cardiac function and vascularity after myocardial infarction. , 2021, Cytotherapy.
[12] R. Verma,et al. Mesenchymal Stem Cells for Cardiac Regeneration: from Differentiation to Cell Delivery , 2021, Stem Cell Reviews and Reports.
[13] R. Bolli,et al. Cell therapy in patients with heart failure: a comprehensive review and emerging concepts , 2021, Cardiovascular research.
[14] J. Laffey,et al. Intra-vital imaging of mesenchymal stromal cell kinetics in the pulmonary vasculature during infection , 2021, Scientific Reports.
[15] H. Tse,et al. Myocardial repair of bioengineered cardiac patches with decellularized placental scaffold and human-induced pluripotent stem cells in a rat model of myocardial infarction , 2021, Stem cell research & therapy.
[16] H. Tse,et al. Immunomodulation by systemic administration of human-induced pluripotent stem cell-derived mesenchymal stromal cells to enhance the therapeutic efficacy of cell-based therapy for treatment of myocardial infarction , 2021, Theranostics.
[17] I. Katrukha,et al. Myocardial Injury and the Release of Troponins I and T in the Blood of Patients. , 2020, Clinical chemistry.
[18] Lei Lei,et al. Tumorigenic and Immunogenic Properties of Induced Pluripotent Stem Cells: a Promising Cancer Vaccine , 2020, Stem Cell Reviews and Reports.
[19] A. Can,et al. Umbilical cord mesenchymal stromal cells engraft and transdifferentiate into cardiomyocyte-like cells following acute myocardial ischemia⋆. , 2020, Acta histochemica.
[20] J. Hartikainen,et al. The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: the BAMI trial , 2020, European heart journal.
[21] Deepak L. Bhatt,et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. , 2020, European heart journal.
[22] M. Nowicki,et al. The Proliferation and Differentiation of Adipose-Derived Stem Cells in Neovascularization and Angiogenesis , 2020, International journal of molecular sciences.
[23] R. Haworth,et al. Accept or Reject: The Role of Immune Tolerance in the Development of Stem Cell Therapies and Possible Future Approaches , 2020, Toxicologic pathology.
[24] Guanwei Fan,et al. Macrophage Activities in Myocardial Infarction and Heart Failure , 2020, Cardiology research and practice.
[25] A. S. Lysenko,et al. Biological activity of mesenchymal stem cells secretome as a basis for cell-free therapeutic approach , 2020 .
[26] S. Miyagawa,et al. Role and therapeutic effects of skeletal muscle-derived non-myogenic cells in a rat myocardial infarction model , 2020, Stem Cell Research & Therapy.
[27] M. Demir,et al. MicroRNA and Cardiovascular Diseases , 2020, Balkan medical journal.
[28] S. Marchianò,et al. Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine , 2020, Nature Reviews Cardiology.
[29] Darcy L. DiFede,et al. Genetic determinants of responsiveness to mesenchymal stem cell injections in non-ischemic dilated cardiomyopathy , 2019, EBioMedicine.
[30] P. di Nardo,et al. Turning regenerative technologies into treatment to repair myocardial injuries , 2019, Journal of cellular and molecular medicine.
[31] J. Hare,et al. Mesenchymal Stem Cell Secretion of SDF-1α Modulates Endothelial Function in Dilated Cardiomyopathy , 2019, Front. Physiol..
[32] A. Salgado,et al. Mesenchymal stem cells secretome: current trends and future challenges , 2019, Neural regeneration research.
[33] Rongchong Huang,et al. Differences in the cargos and functions of exosomes derived from six cardiac cell types: a systematic review , 2019, Stem Cell Research & Therapy.
[34] H. Lauridsen,et al. Myocardial infarction and the immune response - Scarring or regeneration? A comparative look at mammals and popular regenerating animal models , 2019, Journal of Immunology and Regenerative Medicine.
[35] J. T. Afshari,et al. Cardioprotective microRNAs: Lessons from stem cell-derived exosomal microRNAs to treat cardiovascular disease. , 2019, Atherosclerosis.
[36] D. Ding,et al. An in Vivo miRNA Delivery System for Restoring Infarcted Myocardium. , 2019, ACS nano.
[37] T. Litman. Personalized medicine—concepts, technologies, and applications in inflammatory skin diseases , 2019, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[38] M. Marsili,et al. Common Regulatory Pathways Mediate Activity of MicroRNAs Inducing Cardiomyocyte Proliferation , 2019, Cell reports.
[39] R. Lechler,et al. Mesenchymal stem cells inhibit T-cell function through conserved induction of cellular stress , 2019, PloS one.
[40] S. Greenway,et al. Current methods for the maturation of induced pluripotent stem cell-derived cardiomyocytes , 2019, World journal of stem cells.
[41] Xiangjiang Guo,et al. Exosomes Derived from Human Induced Pluripotent Stem Cells-Endothelia Cells Promotes Postnatal Angiogenesis in Mice Bearing Ischemic Limbs , 2019, International journal of biological sciences.
[42] Mahmood Khan,et al. Extracellular Vesicles Released by Human Induced-Pluripotent Stem Cell-Derived Cardiomyocytes Promote Angiogenesis , 2018, Front. Physiol..
[43] Fen Liu,et al. Co-expression of Akt1 and Wnt11 promotes the proliferation and cardiac differentiation of mesenchymal stem cells and attenuates hypoxia/reoxygenation-induced cardiomyocyte apoptosis. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[44] M. Soleimani,et al. Induced pluripotent stem cell‐derived extracellular vesicles: A novel approach for cell‐free regenerative medicine , 2018, Journal of cellular physiology.
[45] M. Lalu,et al. Safety and Efficacy of Adult Stem Cell Therapy for Acute Myocardial Infarction and Ischemic Heart Failure (SafeCell Heart): A Systematic Review and Meta‐Analysis , 2018, Stem cells translational medicine.
[46] Janet Zoldan,et al. Moving iPSC-Derived Cardiomyocytes Forward to Treat Myocardial Infarction. , 2018, Cell stem cell.
[47] K. Hatzistergos,et al. Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges. , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.
[48] M. Sogayar,et al. Extracellular matrix dynamics during mesenchymal stem cells differentiation. , 2018, Developmental biology.
[49] Lil Pabon,et al. Human ESC-Derived Cardiomyocytes Restore Function in Infarcted Hearts of Non-Human Primates , 2018, Nature Biotechnology.
[50] Ling Yu,et al. miR-143-3p inhibits the proliferation, migration and invasion in osteosarcoma by targeting FOSL2 , 2018, Scientific Reports.
[51] Marco Valgimigli,et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.
[52] Rong-Huang Li,et al. Exosomes Derived from Mesenchymal Stem Cells Rescue Myocardial Ischaemia/Reperfusion Injury by Inducing Cardiomyocyte Autophagy Via AMPK and Akt Pathways , 2017, Cellular Physiology and Biochemistry.
[53] O. Wolkenhauer,et al. Cardiac Function Improvement and Bone Marrow Response – , 2017, EBioMedicine.
[54] Doris A Taylor,et al. Global position paper on cardiovascular regenerative medicine , 2017, European heart journal.
[55] J. Butcher,et al. Naturally Engineered Maturation of Cardiomyocytes , 2017, Front. Cell Dev. Biol..
[56] E. Fisher,et al. Inflammatory processes in cardiovascular disease: a route to targeted therapies , 2017, Nature Reviews Cardiology.
[57] Adegbenro Omotuyi John Fakoya,et al. New Delivery Systems of Stem Cells for Vascular Regeneration in Ischemia , 2017, Front. Cardiovasc. Med..
[58] J. Hua,et al. Interactions between mesenchymal stem cells and the immune system , 2017, Cellular and Molecular Life Sciences.
[59] Y. Geng,et al. MiRNA-Sequence Indicates That Mesenchymal Stem Cells and Exosomes Have Similar Mechanism to Enhance Cardiac Repair , 2017, BioMed research international.
[60] P. Benzoni,et al. Human derived cardiomyocytes: A decade of knowledge after the discovery of induced pluripotent stem cells , 2016, Developmental dynamics : an official publication of the American Association of Anatomists.
[61] K. Le Blanc,et al. Mesenchymal Stromal Cell Secretion of Programmed Death‐1 Ligands Regulates T Cell Mediated Immunosuppression , 2016, Stem cells.
[62] Joshua M Hare,et al. Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue. , 2016, Physiological reviews.
[63] D. Yavagal,et al. Intra-arterial delivery of mesenchymal stem cells , 2016, Brain circulation.
[64] C. Romei,et al. Mesenchymal Stromal Cells Induce Peculiar Alternatively Activated Macrophages Capable of Dampening Both Innate and Adaptive Immune Responses , 2016, Stem cells.
[65] M. Rajesh,et al. The Role of Oxidative Stress in Myocardial Ischemia and Reperfusion Injury and Remodeling: Revisited , 2016, Oxidative medicine and cellular longevity.
[66] A. de Becker,et al. Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy? , 2016, World journal of stem cells.
[67] R. Kishore,et al. Tiny Shuttles for Information Transfer: Exosomes in Cardiac Health and Disease , 2016, Journal of Cardiovascular Translational Research.
[68] M. Toungouz,et al. Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells. , 2016, Cytotherapy.
[69] M. Hartman,et al. Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair. , 2016, Advanced drug delivery reviews.
[70] M. Ng,et al. Cardiomyogenic differentiation of human sternal bone marrow mesenchymal stem cells using a combination of basic fibroblast growth factor and hydrocortisone , 2016, Cell biology international.
[71] H. Tse,et al. Insensitivity of Human iPS Cells‐Derived Mesenchymal Stem Cells to Interferon‐γ‐induced HLA Expression Potentiates Repair Efficiency of Hind Limb Ischemia in Immune Humanized NOD Scid Gamma Mice , 2015, Stem cells.
[72] J. Kastrup,et al. A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial , 2015, European heart journal.
[73] R. Bolli,et al. Effect of the stop-flow technique on cardiac retention of c-kit positive human cardiac stem cells after intracoronary infusion in a porcine model of chronic ischemic cardiomyopathy , 2015, Basic Research in Cardiology.
[74] A. Arai. Healing After Myocardial Infarction: A Loosely Defined Process. , 2015, JACC. Cardiovascular imaging.
[75] Ralph Weissleder,et al. Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters , 2015, Nature Communications.
[76] C. Eaves. Hematopoietic stem cells: concepts, definitions, and the new reality. , 2015, Blood.
[77] Tao Wang,et al. A microRNA-Hippo pathway that promotes cardiomyocyte proliferation and cardiac regeneration in mice , 2015, Science Translational Medicine.
[78] Meifeng Xu,et al. Exosomes secreted from GATA-4 overexpressing mesenchymal stem cells serve as a reservoir of anti-apoptotic microRNAs for cardioprotection. , 2015, International journal of cardiology.
[79] Jung Bok Lee,et al. Somatic transcriptome priming gates lineage-specific differentiation potential of human-induced pluripotent stem cell states , 2014, Nature Communications.
[80] P. Goichberg,et al. Cardiac stem cell niches. , 2014, Stem cell research.
[81] Wei Cao,et al. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications , 2014, Nature Immunology.
[82] M. Won,et al. Multiple paracrine factors secreted by mesenchymal stem cells contribute to angiogenesis. , 2014, Vascular pharmacology.
[83] Misha Angrist,et al. Personalized medicine and human genetic diversity. , 2014, Cold Spring Harbor perspectives in medicine.
[84] Valeria V Orlova,et al. Generation, expansion and functional analysis of endothelial cells and pericytes derived from human pluripotent stem cells , 2014, Nature Protocols.
[85] Charles E. Murry,et al. Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate Non-Human Primate Hearts , 2014, Nature.
[86] H. Huikuri,et al. Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis. , 2014, European heart journal.
[87] S. Ramakrishna,et al. Gold nanoparticle loaded hybrid nanofibers for cardiogenic differentiation of stem cells for infarcted myocardium regeneration. , 2014, Macromolecular bioscience.
[88] J. Li,et al. miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer , 2014, Oncogene.
[89] J. Karp,et al. Mesenchymal stem cells: immune evasive, not immune privileged , 2014, Nature Biotechnology.
[90] R. Bonow,et al. Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction). , 2014, Journal of the American College of Cardiology.
[91] K. Fukuda,et al. Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction. , 2013, Journal of molecular and cellular cardiology.
[92] Dinender K Singla,et al. Transplanted induced pluripotent stem cells mitigate oxidative stress and improve cardiac function through the Akt cell survival pathway in diabetic cardiomyopathy. , 2013, Molecular pharmaceutics.
[93] S. Yamanaka,et al. To be immunogenic, or not to be: that's the iPSC question. , 2013, Cell stem cell.
[94] K. Channon,et al. Angiogenesis in the infarcted myocardium. , 2013, Antioxidants & redox signaling.
[95] Alla Katsnelson,et al. Momentum grows to make 'personalized' medicine more 'precise' , 2013, Nature Medicine.
[96] Doris A Taylor,et al. Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial. , 2012, JAMA.
[97] H. Shimokawa,et al. Coronary perivascular fibrosis is associated with impairment of coronary blood flow in patients with non-ischemic heart failure. , 2012, Journal of cardiology.
[98] M. Zöller,et al. Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection. , 2012, The international journal of biochemistry & cell biology.
[99] Patrick W Serruys,et al. First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction. , 2012, Journal of the American College of Cardiology.
[100] F. Prósper,et al. Mesenchymal Stem Cells and Cardiovascular Disease: A Bench to Bedside Roadmap , 2012, Stem cells international.
[101] Doris A Taylor,et al. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. , 2011, JAMA.
[102] M. Ashraf,et al. Reduced collagen deposition in infarcted myocardium facilitates induced pluripotent stem cell engraftment and angiomyogenesis for improvement of left ventricular function. , 2011, Journal of the American College of Cardiology.
[103] H. Masuda,et al. R EGENERATIVE M EDICINE Concise Review: Circulating Endothelial Progenitor Cells for Vascular Medicine , 2022 .
[104] A. Haverich,et al. Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. , 2011, European heart journal.
[105] R. Pochampally,et al. Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic. , 2011, Stem cell research.
[106] M. Goumans,et al. Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. , 2011, Stem cell research.
[107] Richard T. Lee,et al. Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. , 2011, Cell stem cell.
[108] A. J. Putnam,et al. Mesenchymal stem cells from adipose and bone marrow promote angiogenesis via distinct cytokine and protease expression mechanisms , 2011, Angiogenesis.
[109] I. Komuro,et al. Implantation of cardiac progenitor cells using self-assembling peptide improves cardiac function after myocardial infarction. , 2010, Journal of molecular and cellular cardiology.
[110] Gerard Pasterkamp,et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. , 2010, Stem cell research.
[111] M. Taljaard,et al. Rationale and design of Enhanced Angiogenic Cell Therapy in Acute Myocardial Infarction (ENACT-AMI): the first randomized placebo-controlled trial of enhanced progenitor cell therapy for acute myocardial infarction. , 2010, American heart journal.
[112] Joshua M Hare,et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. , 2009, Journal of the American College of Cardiology.
[113] Lei Zhang,et al. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats. , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[114] B. Tomanek,et al. Adipose-derived stem cells are an effective cell candidate for treatment of heart failure: an MR imaging study of rat hearts. , 2009, American journal of physiology. Heart and circulatory physiology.
[115] P. Pattany,et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity , 2009, Proceedings of the National Academy of Sciences.
[116] F. Burzotta,et al. Myocardial no-reflow in humans. , 2009, Journal of the American College of Cardiology.
[117] P. Delafontaine,et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. , 2009, Cell stem cell.
[118] F. Cao,et al. Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up , 2009, European heart journal.
[119] Raquel P. Ritchie,et al. A comparison of murine smooth muscle cells generated from embryonic versus induced pluripotent stem cells. , 2009, Stem cells and development.
[120] S. Savitz,et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. , 2009, Stem cells and development.
[121] Jeffrey M Karp,et al. Mesenchymal stem cell homing: the devil is in the details. , 2009, Cell stem cell.
[122] Samuel Bernard,et al. Evidence for Cardiomyocyte Renewal in Humans , 2008, Science.
[123] P. Menasché. Skeletal myoblasts and cardiac repair. , 2008, Journal of molecular and cellular cardiology.
[124] E. Martin-Rendon,et al. 5‐Azacytidine‐treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies , 2008, Vox sanguinis.
[125] P. Doevendans,et al. Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction. , 2008, Cardiovascular research.
[126] R. Zhao,et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. , 2008, Cell Stem Cell.
[127] L. Moretta,et al. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. , 2008, Blood.
[128] T. Ichisaka,et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.
[129] Yao‐Hua Song,et al. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. , 2007, European heart journal.
[130] S. Yamanaka. Strategies and new developments in the generation of patient-specific pluripotent stem cells. , 2007, Cell stem cell.
[131] Guosheng Lin,et al. Anti-Inflammation Role for Mesenchymal Stem Cells Transplantation in Myocardial Infarction , 2007, Inflammation.
[132] R. Robbins,et al. Stem cell transplantation: the lung barrier. , 2007, Transplantation proceedings.
[133] Sunil V. Rao,et al. REPAIR-AMI: stem cells for acute myocardial infarction. , 2007, Future cardiology.
[134] M. Fujita,et al. Repeated implantation is a more effective cell delivery method in skeletal myoblast transplantation for rat myocardial infarction. , 2006, Circulation journal : official journal of the Japanese Circulation Society.
[135] Hanns-Ulrich Marschall,et al. Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease , 2006, Transplantation.
[136] J. Ingwall,et al. Evidence supporting paracrine hypothesis for Akt‐modified mesenchymal stem cell‐mediated cardiac protection and functional improvement , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[137] Min Zhu,et al. Human adipose tissue is a source of multipotent stem cells. , 2002, Molecular biology of the cell.
[138] R. Pedersen,et al. Stem cell medicine encounters the immune system , 2002, Nature Reviews Immunology.
[139] H. Lorenz,et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. , 2001, Tissue engineering.
[140] A. Hagège,et al. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. , 2000, The Journal of thoracic and cardiovascular surgery.
[141] Vishva Dixit,et al. Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway , 1998, The Journal of Biological Chemistry.
[142] J. Thomson,et al. Embryonic stem cell lines derived from human blastocysts. , 1998, Science.
[143] G. Martin,et al. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[144] A. Cutler,et al. Efficient expansion of mesenchymal stromal cells from umbilical cord under low serum conditions. , 2009, Cytotherapy.
[145] J. Robertson. Human embryonic stem cell research: ethical and legal issues , 2001, Nature Reviews Genetics.
[146] A I Caplan,et al. Characterization of cells with osteogenic potential from human marrow. , 1992, Bone.